반응형
https://www.dailypharm.com/user/news/343840
[데일리팜]항암제 병용 덜어낼까…'키트루다', 자궁내막암서 근거 추가
[스페인 마드리드=손형민 기자] 키트루다가 일부 자궁내막암 환자에서 항암화학요법 없이 첫 치료를 시작할 가능성을 제시했다. 26일 유럽종양학회 연례학술대회(ESMO 2026) 프레지덴셜 심포지엄
www.dailypharm.com
Keytruda presented
the possibility of
starting first-line treatment
without chemotherapy in
some patients with
endometrial cancer.
This study compared
Keytruda monotherapy with
chemotherapy combination therapy
in patients with advanced or
recurrent endometrial cancer
with dMMR.
Keytruda monotherapy
showed improvement in
PFS and quality of life benefits,
suggesting the potential to
replace chemotherapy
for some patients.
반응형
댓글